SHC
Overvalued by 142.3% based on the discounted cash flow analysis.
Market cap | $3.72 Billion |
---|---|
Enterprise Value | $5.78 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.18 |
Beta | 2.08 |
Outstanding Shares | 283,059,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 52.53 |
---|---|
PEG | -23.41 |
Price to Sales | 4.38 |
Price to Book Ratio | 13.13 |
Enterprise Value to Revenue | 5.16 |
Enterprise Value to EBIT | 18.85 |
Enterprise Value to Net Income | 81 |
Total Debt to Enterprise | 0.41 |
Debt to Equity | 5.04 |
No data
No data
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses - Sterigen...